Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Prospective Studies [NCBI]


Gene


Gene Link Information
Gain
01




OMIM


OMIM Link Information
gain
01
apnea, obstructive sleep [NCBI] 0.016764
VRNI [NCBI] 0.00483768
IS1 [NCBI] 0.00374499
RA [NCBI] 0.00348351
KLK3 [NCBI] 0.00282119
SLE [NCBI] 0.00118768
vitreoretinal degeneration, snowflake type [NCBI] 0.000982519
CEACAM5 [NCBI] 0.000957365
temporal arteritis [NCBI] 0.00063856
PTH [NCBI] 0.000619911
CRC [NCBI] 0.000558864
MDD [NCBI] 0.000552594
SHBG [NCBI] 0.000524673
CD [NCBI] 0.000356943
OD [NCBI] 0.000338095
EPO [NCBI] 0.000324361
pelvic organ prolapse [NCBI] 0.000316935
cataract, age-related cortical [NCBI] 0.000316935
testicular microlithiasis [NCBI] 0.000316935
AFP [NCBI] 0.000297173
TNF [NCBI] 0.000271189
CF [NCBI] 0.000263597
nipples, supernumerary [NCBI] 0.000257752
otitis media, susceptibility to [NCBI] 0.000257752
PD [NCBI] 0.000250485
EGF [NCBI] 0.000244983
FA [NCBI] 0.000237713
abdominal obesity-metabolic syndrome [NCBI] 0.000233637
behcet syndrome [NCBI] 0.000229656
aneurysm, intracranial berry, 1 [NCBI] 0.000217552
FECD2 [NCBI] 0.000215237
cerebral palsy, ataxic, autosomal recessive [NCBI] 0.000215237
lethal congenital contracture syndrome 1 [NCBI] 0.000215237
NGFB [NCBI] 0.000209468
VUR1 [NCBI] 0.000202655
chiari malformation type i [NCBI] 0.000202655
thrombocytopenic purpura, autoimmune [NCBI] 0.000189264
panbronchiolitis, diffuse [NCBI] 0.00018254
MVP [NCBI] 0.000175951
MBL2 [NCBI] 0.000163001
RNASE3 [NCBI] 0.000161977
IH [NCBI] 0.000156332
NYS2 [NCBI] 0.000156332
PWS [NCBI] 0.000147407
APOE [NCBI] 0.000143594
panencephalitis, subacute sclerosing [NCBI] 0.000140483
TG [NCBI] 0.00012828
TH [NCBI] 0.000126312
histidinemia [NCBI] 0.000124628
ARMD1 [NCBI] 0.000120944
MAFD6 [NCBI] 0.000118715
AMH [NCBI] 0.000115357
BWS [NCBI] 0.000114219
MAFD1 [NCBI] 0.000111579
palatopharyngeal incompetence [NCBI] 0.000106518
CMM [NCBI] 0.000103733
centralopathic epilepsy [NCBI] 0.000101114
melanoma, uveal [NCBI] 0.00010018
CRP [NCBI] 9.91284e-05
ALB [NCBI] 9.34237e-05
VEGF [NCBI] 9.18725e-05
AT [NCBI] 9.12131e-05
GBD1 [NCBI] 8.92403e-05
sjogren syndrome [NCBI] 8.77797e-05
KTCN1 [NCBI] 8.59983e-05
LBP [NCBI] 8.5167e-05
MFS [NCBI] 8.5113e-05
ACHE [NCBI] 8.45766e-05
PAEP [NCBI] 7.99567e-05
TFPI [NCBI] 7.58746e-05
IFNA1 [NCBI] 7.37969e-05
breath-holding spells [NCBI] 7.25762e-05
VIP [NCBI] 7.04331e-05
GFAP [NCBI] 6.6429e-05
TSD [NCBI] 6.51996e-05
NPY [NCBI] 6.48683e-05
RTT [NCBI] 6.20558e-05
AD [NCBI] 6.13376e-05
PGR [NCBI] 6.05142e-05
BDNF [NCBI] 5.95425e-05
MBP [NCBI] 5.92175e-05
MJD [NCBI] 5.77184e-05
BFH [NCBI] 5.73896e-05
MYP2 [NCBI] 5.71644e-05
PCOS1 [NCBI] 5.68938e-05
ADA [NCBI] 5.65114e-05
ALD [NCBI] 5.43846e-05
CPB2 [NCBI] 5.13423e-05
PF4 [NCBI] 5.12707e-05
glaucoma-related pigment dispersion syndrome [NCBI] 4.93201e-05
BGLAP [NCBI] 4.83939e-05
AIS [NCBI] 4.55417e-05
ASD2 [NCBI] 4.18945e-05
cataract, lamellar 2 [NCBI] 4.18945e-05
PXE [NCBI] 4.09282e-05
klippel-trenaunay-weber syndrome [NCBI] 3.98734e-05
osteoporosis [NCBI] 3.95488e-05
CSF3 [NCBI] 3.83657e-05
EIG [NCBI] 3.73969e-05
GPS [NCBI] 3.62592e-05
cayler cardiofacial syndrome [NCBI] 3.62592e-05
angioid streaks [NCBI] 3.20609e-05
retinitis pigmentosa, late-adult onset [NCBI] 3.20609e-05
phace association [NCBI] 3.20609e-05
ARVD11 [NCBI] 3.20609e-05
dermatitis herpetiformis, familial [NCBI] 3.20609e-05
cataract, age-related nuclear [NCBI] 3.20609e-05
cushing disease, pituitary [NCBI] 3.20609e-05
hepatitis b vaccine, response to [NCBI] 3.20609e-05
DMD [NCBI] 3.19046e-05
CXADR [NCBI] 3.12406e-05
REG3A [NCBI] 3.0989e-05
CNTF [NCBI] 3.09001e-05
ATHS [NCBI] 3.08339e-05
KRT20 [NCBI] 3.07818e-05
ADIPOQ [NCBI] 2.97886e-05
CTHM [NCBI] 2.84804e-05
AVSD [NCBI] 2.81894e-05
DHFR [NCBI] 2.75684e-05
OCP [NCBI] 2.6722e-05
ESR1 [NCBI] 2.66272e-05
DFSP [NCBI] 2.65377e-05
CVID [NCBI] 2.64157e-05
EV [NCBI] 2.62211e-05
MS [NCBI] 2.62211e-05
CFH [NCBI] 2.61581e-05
resting heart rate [NCBI] 2.59027e-05
isotretinoin embryopathy-like syndrome [NCBI] 2.59027e-05
CORD6 [NCBI] 2.59027e-05
hydroxyprolinemia [NCBI] 2.59027e-05
ACPP [NCBI] 2.57299e-05
PCNA [NCBI] 2.45085e-05
GAPDH [NCBI] 2.43191e-05
EVA [NCBI] 2.39156e-05
GNRH1 [NCBI] 2.38269e-05
VDR [NCBI] 2.37453e-05
FRDA [NCBI] 2.34367e-05
CMH [NCBI] 2.29789e-05
TNFRSF11B [NCBI] 2.28946e-05
TF [NCBI] 2.23793e-05
MCDR1 [NCBI] 2.17985e-05
polycystic kidneys [NCBI] 2.16554e-05
CFTR [NCBI] 2.15458e-05
recombinant chromosome 8 syndrome [NCBI] 2.149e-05
melanoma-pancreatic cancer syndrome [NCBI] 2.149e-05
intracranial hypertension, idiopathic [NCBI] 2.149e-05
TNFSF6 [NCBI] 2.14861e-05
ADHD [NCBI] 2.10781e-05
brugada syndrome 1 [NCBI] 2.09943e-05
PON1 [NCBI] 2.08595e-05
OPMD [NCBI] 2.07188e-05
RP [NCBI] 2.01872e-05
APC [NCBI] 2.01492e-05
PG [NCBI] 2.01347e-05
ANG [NCBI] 1.99563e-05
stroke, ischemic [NCBI] 1.94752e-05
AR [NCBI] 1.93021e-05
GTS [NCBI] 1.89745e-05
SCA1 [NCBI] 1.89479e-05
COMP [NCBI] 1.82855e-05
corneal dystrophy, epithelial basement membrane [NCBI] 1.81055e-05
FOLH1 [NCBI] 1.80822e-05
FFI [NCBI] 1.80758e-05
scleroderma, familial progressive [NCBI] 1.80662e-05
CCK [NCBI] 1.78459e-05
FSHMD1A [NCBI] 1.7286e-05
factor v deficiency [NCBI] 1.69766e-05
CNC1 [NCBI] 1.67603e-05
MTHFR [NCBI] 1.67537e-05
TYMS [NCBI] 1.6695e-05
FGF23 [NCBI] 1.58189e-05
sudden infant death syndrome [NCBI] 1.55444e-05
cerebral palsy, spastic, symmetric, autosomal recessive [NCBI] 1.54003e-05
pancreatic cancer, susceptibility to, 1 [NCBI] 1.54003e-05
drug metabolism, poor, cyp2c19-related [NCBI] 1.54003e-05
sturge-weber syndrome [NCBI] 1.54003e-05
CJD [NCBI] 1.51311e-05
SELP [NCBI] 1.46499e-05
MEN1 [NCBI] 1.45124e-05
dystrophia myotonica 1 [NCBI] 1.45099e-05
CRMO [NCBI] 1.44114e-05
acyl-coa dehydrogenase, medium-chain, deficiency of [NCBI] 1.44114e-05
HPS [NCBI] 1.4197e-05
HSCR1 [NCBI] 1.38585e-05
SPP1 [NCBI] 1.38276e-05
ZNF202 [NCBI] 1.36632e-05
LGALS13 [NCBI] 1.36632e-05
aortic valve disease [NCBI] 1.35266e-05
GH1 [NCBI] 1.32618e-05
CRH [NCBI] 1.32557e-05
creatine deficiency syndrome, x-linked [NCBI] 1.31779e-05
antiphospholipid syndrome [NCBI] 1.31779e-05
hyperbilirubinemia, transient familial neonatal [NCBI] 1.31779e-05
wilson disease [NCBI] 1.30562e-05
SOD2 [NCBI] 1.24839e-05
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency [NCBI] 1.22598e-05
LS [NCBI] 1.22598e-05
SLC34A2 [NCBI] 1.22256e-05
GAL [NCBI] 1.21197e-05
FABP2 [NCBI] 1.18201e-05
amyloidosis vi [NCBI] 1.15832e-05
SLOS [NCBI] 1.13588e-05
aspirin resistance [NCBI] 1.13166e-05
macular dystrophy, vitelliform, adult-onset [NCBI] 1.13166e-05
KIR2DL3 [NCBI] 1.10933e-05
KIR2DL2 [NCBI] 1.10933e-05
PJS [NCBI] 1.10817e-05
IL18 [NCBI] 1.08451e-05
GRA [NCBI] 1.08348e-05
MAG [NCBI] 1.06981e-05
IL10 [NCBI] 1.06966e-05
lymphoma, non-hodgkin, familial [NCBI] 1.06242e-05
ACE [NCBI] 1.04621e-05
CCD [NCBI] 1.03275e-05
MIA [NCBI] 1.01626e-05
HLA-DPB1 [NCBI] 1.01626e-05
FIP1L1 [NCBI] 1.01626e-05
CRYBA4 [NCBI] 1.01626e-05
FABP4 [NCBI] 1.01626e-05
GIP [NCBI] 1.00984e-05
PI [NCBI] 1.00563e-05
breast cancer [NCBI] 9.95175e-06
STAT3 [NCBI] 9.75135e-06
hydrocephalus [NCBI] 9.7355e-06
ICAM1 [NCBI] 9.70554e-06
TS [NCBI] 9.66802e-06
SCA2 [NCBI] 9.57986e-06
PTGFR [NCBI] 9.37541e-06
CTGF [NCBI] 9.23571e-06
alopecia, androgenetic [NCBI] 9.21191e-06
PSCA [NCBI] 9.19322e-06
LTA [NCBI] 9.19322e-06
HRG [NCBI] 9.01559e-06
LSA [NCBI] 9.01531e-06
homocysteinemia [NCBI] 9.01531e-06
graves disease [NCBI] 9.01531e-06
SLPI [NCBI] 8.69637e-06
FGF20 [NCBI] 8.69539e-06
SOD3 [NCBI] 8.69539e-06
HTR2C [NCBI] 8.69539e-06
MPO [NCBI] 8.64568e-06
SLC6A3 [NCBI] 8.59225e-06
LCAT [NCBI] 8.43421e-06
WSS [NCBI] 8.37826e-06
cirrhosis, familial [NCBI] 8.37826e-06
FGF7 [NCBI] 8.15119e-06
ALS1 [NCBI] 8.13276e-06
CAT [NCBI] 8.08589e-06
HLA-DRA [NCBI] 8.04997e-06
SST [NCBI] 7.93783e-06
LPA [NCBI] 7.84196e-06
HK2 [NCBI] 7.56824e-06
CMT1A [NCBI] 7.43516e-06
ACP5 [NCBI] 7.32853e-06
AOS [NCBI] 7.31649e-06
sarcoidosis [NCBI] 7.20401e-06
BCHE [NCBI] 7.20186e-06
loc387715 gene [NCBI] 7.09224e-06
ITPA [NCBI] 7.09224e-06
KIR2DL1 [NCBI] 7.09224e-06
APCS [NCBI] 7.0688e-06
PZP [NCBI] 7.0688e-06
TCF7L2 [NCBI] 7.0688e-06
JMML [NCBI] 6.90458e-06
LQT1 [NCBI] 6.67196e-06
CRYGC [NCBI] 6.66148e-06
ABCC1 [NCBI] 6.47432e-06
CMD1A [NCBI] 6.43405e-06
IL6 [NCBI] 6.34884e-06
MUC1 [NCBI] 6.31104e-06
hypercholesterolemia, autosomal dominant [NCBI] 6.30909e-06
CDX2 [NCBI] 6.26898e-06
GDF15 [NCBI] 6.26898e-06
thiopurine s-methyltransferase deficiency [NCBI] 6.18212e-06
autoimmune disease [NCBI] 6.18212e-06
XFS [NCBI] 6.18212e-06
SVAS [NCBI] 6.09733e-06
B2M [NCBI] 6.06066e-06
MAP2 [NCBI] 6.05597e-06
CRYGD [NCBI] 5.90926e-06
HIC1 [NCBI] 5.90926e-06
TNNI3 [NCBI] 5.90926e-06
FSHB [NCBI] 5.90926e-06
HABP2 [NCBI] 5.90926e-06
CADASIL [NCBI] 5.88703e-06
ABP1 [NCBI] 5.62052e-06
A2M [NCBI] 5.61402e-06
SOD1 [NCBI] 5.60985e-06
TBX21 [NCBI] 5.57794e-06
ALOX5AP [NCBI] 5.57794e-06
SCZD [NCBI] 5.54311e-06
ACH [NCBI] 5.5303e-06
ADM [NCBI] 5.52154e-06
restless legs syndrome, susceptibility to, 1 [NCBI] 5.5032e-06
prostate cancer [NCBI] 5.45962e-06
malaria, susceptibility to [NCBI] 5.37471e-06
VHL [NCBI] 5.29571e-06
LGMD2I [NCBI] 5.28908e-06
tetralogy of fallot [NCBI] 5.28908e-06
ARMD4 [NCBI] 5.28908e-06
ADRB1 [NCBI] 5.27146e-06
IGF1 [NCBI] 5.06929e-06
ALPS [NCBI] 5.05241e-06
SCNN1B [NCBI] 4.9869e-06
GNB3 [NCBI] 4.9869e-06
AMFR [NCBI] 4.9869e-06
KRAS [NCBI] 4.94138e-06
porphyria variegata [NCBI] 4.7335e-06
CYP1A1 [NCBI] 4.73206e-06
BHMT [NCBI] 4.72181e-06
PAPPA [NCBI] 4.72181e-06
IL6R [NCBI] 4.72181e-06
APOB [NCBI] 4.50437e-06
AKR1B1 [NCBI] 4.48774e-06
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of [NCBI] 4.47414e-06
GUCY2D [NCBI] 4.47414e-06
SLC6A8 [NCBI] 4.47414e-06
HFM [NCBI] 4.44778e-06
aHUS [NCBI] 4.44657e-06
CCL17 [NCBI] 4.2357e-06
CP [NCBI] 4.20365e-06
SSTR2 [NCBI] 4.02433e-06
CCL2 [NCBI] 4.02194e-06
SLS [NCBI] 3.96814e-06
SERPINA6 [NCBI] 3.88077e-06
BRCA1 [NCBI] 3.86865e-06
diabetes insipidus, neurohypophyseal type [NCBI] 3.81943e-06
GCE [NCBI] 3.81943e-06
TTP [NCBI] 3.81943e-06
alexander disease [NCBI] 3.81943e-06
AMPD1 [NCBI] 3.81942e-06
GATA4 [NCBI] 3.81942e-06
DLK1 [NCBI] 3.81942e-06
FGFR3 [NCBI] 3.73554e-06
POAG [NCBI] 3.6358e-06
LKS [NCBI] 3.6358e-06
LAMB3 [NCBI] 3.62627e-06
RHD [NCBI] 3.62627e-06
TLR2 [NCBI] 3.58778e-06
PRL [NCBI] 3.58526e-06
XDH [NCBI] 3.51807e-06
BIRC5 [NCBI] 3.44391e-06
G6PD [NCBI] 3.40494e-06
EGFR [NCBI] 3.37487e-06
MG [NCBI] 3.36039e-06
MLH1 [NCBI] 3.34694e-06
FKRP [NCBI] 3.27147e-06
HLA-DRB1 [NCBI] 3.27147e-06
NKX2E [NCBI] 3.27147e-06
AQP5 [NCBI] 3.27147e-06
SLC3A1 [NCBI] 3.27147e-06
SCCMS [NCBI] 3.21608e-06
hyperlipoproteinemia, type i [NCBI] 3.21608e-06
CORD2 [NCBI] 3.21608e-06
ICP [NCBI] 3.21608e-06
diabetes-deafness syndrome, maternally transmitted [NCBI] 3.21608e-06
pituitary dwarfism iii [NCBI] 3.21608e-06
ALK [NCBI] 3.183e-06
HTR2A [NCBI] 3.1082e-06
fabry disease [NCBI] 3.06188e-06
NPPA [NCBI] 3.04665e-06
hla-d histocompatibility type [NCBI] 2.97175e-06
CTSK [NCBI] 2.9534e-06
OPA1 [NCBI] 2.9534e-06
SFRP1 [NCBI] 2.9534e-06
MTR [NCBI] 2.92627e-06
leber optic atrophy [NCBI] 2.81469e-06
GAS [NCBI] 2.80648e-06
TNNT2 [NCBI] 2.80648e-06
PROP1 [NCBI] 2.80648e-06
GPX1 [NCBI] 2.80648e-06
TPO [NCBI] 2.70129e-06
glucose transport defect, blood-brain barrier [NCBI] 2.68654e-06
FTLDU [NCBI] 2.68654e-06
SHEP2 [NCBI] 2.68654e-06
factor xii deficiency [NCBI] 2.68654e-06
MB [NCBI] 2.6604e-06
HHF2 [NCBI] 2.64625e-06
CCM [NCBI] 2.64625e-06
AN2 [NCBI] 2.64625e-06
MHS1 [NCBI] 2.64625e-06
NOS2A [NCBI] 2.53415e-06
danubian endemic familial nephropathy [NCBI] 2.48584e-06
PEDF [NCBI] 2.41581e-06
IRS2 [NCBI] 2.40781e-06
complement component 6 deficiency [NCBI] 2.40781e-06
MSH6 [NCBI] 2.40781e-06
HNPP [NCBI] 2.40521e-06
NF2 [NCBI] 2.40521e-06
sickle cell anemia [NCBI] 2.40521e-06
VASP [NCBI] 2.38662e-06
LAM [NCBI] 2.30224e-06
neuraminidase deficiency with beta-galactosidase deficiency [NCBI] 2.28746e-06
GCH1 [NCBI] 2.28746e-06
CETP [NCBI] 2.28746e-06
HRPT1 [NCBI] 2.22259e-06
osteogenesis imperfecta, type iv [NCBI] 2.22259e-06
pancreatic carcinoma [NCBI] 2.22259e-06
ENPP1 [NCBI] 2.17276e-06
IL8 [NCBI] 2.17276e-06
MAOB [NCBI] 2.17276e-06
FASN [NCBI] 2.17276e-06
galactosemia [NCBI] 2.1727e-06
MAS [NCBI] 2.12876e-06
lynch syndrome i [NCBI] 2.03308e-06
SDS [NCBI] 2.03308e-06
homocystinuria [NCBI] 1.96894e-06
PPARA [NCBI] 1.95412e-06
ACADM [NCBI] 1.92312e-06
DAP [NCBI] 1.85928e-06
GHRL [NCBI] 1.85928e-06
EPHX1 [NCBI] 1.85928e-06
IL13 [NCBI] 1.85928e-06
LEPR [NCBI] 1.79958e-06
thyroid carcinoma, papillary [NCBI] 1.79832e-06
APP [NCBI] 1.76708e-06
PAI1 [NCBI] 1.76407e-06
SCA6 [NCBI] 1.73473e-06
ornithine aminotransferase deficiency [NCBI] 1.6731e-06
HDGF [NCBI] 1.58614e-06
PTPRC [NCBI] 1.58614e-06
OPTN [NCBI] 1.58614e-06
SCIDX1 [NCBI] 1.53008e-06
GAMT [NCBI] 1.503e-06
pfeiffer syndrome [NCBI] 1.46484e-06
osteogenesis imperfecta, type iii [NCBI] 1.46484e-06
mismatch repair cancer syndrome [NCBI] 1.46484e-06
TNFRSF1B [NCBI] 1.42348e-06
GRN [NCBI] 1.42348e-06
FGFR2 [NCBI] 1.36099e-06
CSF2 [NCBI] 1.34743e-06
TP53 [NCBI] 1.32972e-06
MMP3 [NCBI] 1.27466e-06
CASR [NCBI] 1.2431e-06
F3 [NCBI] 1.22684e-06
LPL [NCBI] 1.22328e-06
BRAF [NCBI] 1.20505e-06
GHR [NCBI] 1.19265e-06
AVP [NCBI] 1.16582e-06
obesity [NCBI] 1.16081e-06
aortic aneurysm, abdominal [NCBI] 1.16013e-06
PPH1 [NCBI] 1.16013e-06
mucolipidosis iv [NCBI] 1.16013e-06
JPS [NCBI] 1.15164e-06
XPA [NCBI] 1.15164e-06
ENG [NCBI] 1.13844e-06
NF1 [NCBI] 1.08275e-06
DAZ [NCBI] 1.0747e-06
PTEN [NCBI] 1.07308e-06
porphyria cutanea tarda [NCBI] 1.01372e-06
HSAN3 [NCBI] 9.78819e-07
TSC1 [NCBI] 9.55374e-07
NS1 [NCBI] 9.397e-07
PPARG [NCBI] 9.22132e-07
CHNG2 [NCBI] 8.98842e-07
PRF1 [NCBI] 8.46174e-07
COL3A1 [NCBI] 8.46174e-07
SCA7 [NCBI] 8.24195e-07
BMD [NCBI] 8.1765e-07
RP2 [NCBI] 7.95122e-07
TPMT [NCBI] 7.91159e-07
SPINK1 [NCBI] 7.01239e-07
CFB [NCBI] 6.99666e-07
HGF [NCBI] 6.82621e-07
SCDO1 [NCBI] 6.77198e-07
andersen cardiodysrhythmic periodic paralysis [NCBI] 6.77198e-07
hypophosphatemic rickets, x-linked dominant [NCBI] 6.6871e-07
PYY [NCBI] 6.59905e-07
PPR [NCBI] 6.56815e-07
AGT [NCBI] 6.55097e-07
ABL1 [NCBI] 6.12532e-07
IGFALS [NCBI] 5.91792e-07
BRCA2 [NCBI] 5.73819e-07
MSH2 [NCBI] 5.719e-07
MYH7 [NCBI] 5.719e-07
KIT [NCBI] 5.719e-07
HHF1 [NCBI] 5.32626e-07
RET [NCBI] 5.30367e-07
osteogenesis imperfecta, type i [NCBI] 5.06717e-07
DCC [NCBI] 4.96163e-07
NAT1 [NCBI] 4.96163e-07
DRD2 [NCBI] 4.96163e-07
SPS [NCBI] 4.63504e-07
hurler syndrome [NCBI] 4.38149e-07
von willebrand disease [NCBI] 4.27587e-07
CDKN2A [NCBI] 4.27587e-07
INS [NCBI] 4.10222e-07
HD [NCBI] 4.03832e-07
CCND1 [NCBI] 3.88923e-07
MAPT [NCBI] 3.70138e-07
NOS3 [NCBI] 3.65115e-07
DGS [NCBI] 3.64393e-07
phenylketonuria [NCBI] 3.51248e-07
lung cancer [NCBI] 3.40012e-07
osteoarthritis [NCBI] 3.40012e-07
JAK2 [NCBI] 3.37367e-07
ITGB3 [NCBI] 3.3629e-07
PKD1 [NCBI] 3.16038e-07
UCP2 [NCBI] 3.16038e-07
LCN2 [NCBI] 3.08941e-07
CYP19A1 [NCBI] 3.08941e-07
lactase persistence [NCBI] 3.01786e-07
LFS1 [NCBI] 3.01786e-07
COH1 [NCBI] 3.01786e-07
OCA1A [NCBI] 3.01786e-07
NPM1 [NCBI] 2.98778e-07
UGT1A1 [NCBI] 2.83023e-07
TLR9 [NCBI] 2.65453e-07
RNASE2 [NCBI] 2.49402e-07
NMU [NCBI] 2.35307e-07
DFNB1 [NCBI] 2.18988e-07
AGER [NCBI] 2.1522e-07
PLG [NCBI] 2.08787e-07
SMA3 [NCBI] 2.08554e-07
OPA1 [NCBI] 2.08554e-07
vitamin d-dependent rickets, type ii [NCBI] 2.08554e-07
kartagener syndrome [NCBI] 2.08554e-07
PLAUR [NCBI] 2.0378e-07
PTHLH [NCBI] 1.98229e-07
protein c deficiency, congenital thrombotic disease due to [NCBI] 1.92818e-07
HMBS [NCBI] 1.87791e-07
MAOA [NCBI] 1.75546e-07
TFF3 [NCBI] 1.73439e-07
PCI [NCBI] 1.62107e-07
TTR [NCBI] 1.55224e-07
PHS [NCBI] 1.26534e-07
HSAS [NCBI] 1.26534e-07
TSC2 [NCBI] 1.22357e-07
MC4R [NCBI] 1.22357e-07
LOX [NCBI] 1.07574e-07
FSHR [NCBI] 1.07574e-07
COMT [NCBI] 1.06168e-07
MC1R [NCBI] 1.02009e-07
MVP [NCBI] 9.3864e-08
SLC4A1 [NCBI] 9.3864e-08
LEP [NCBI] 8.94432e-08
GHRH [NCBI] 8.42284e-08
GIST [NCBI] 8.38011e-08
SPG4 [NCBI] 7.07742e-08
PARK2 [NCBI] 6.95485e-08
FTD [NCBI] 6.9176e-08
APOA1 [NCBI] 5.88902e-08
RYR1 [NCBI] 5.88902e-08
FMF [NCBI] 5.85369e-08
LMNA [NCBI] 5.45667e-08
UGB [NCBI] 4.91977e-08
IL4 [NCBI] 4.67038e-08
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency [NCBI] 4.20807e-08
CCL22 [NCBI] 4.0447e-08
PCD [NCBI] 3.00504e-08
PARK2 [NCBI] 2.81835e-08
CVS [NCBI] 2.81835e-08
CPI [NCBI] 2.75602e-08
GJB2 [NCBI] 1.63672e-08
HP [NCBI] 1.63561e-08
HFE [NCBI] 1.32047e-08
ABCC2 [NCBI] 1.18294e-08
GCK [NCBI] 8.18039e-09
periodic fever, familial, autosomal dominant [NCBI] 4.58322e-09
cystinuria [NCBI] 4.58322e-09
ZFP36 [NCBI] 3.70892e-09
CHH [NCBI] 2.39806e-09
TNFRSF1A [NCBI] 1.20528e-09
MEN2A [NCBI] 5.65726e-10
TLR4 [NCBI] 2.6658e-14




Database Center for Life Science